Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bromodomain‐containing protein 4 inhibitor JQ1 promotes melanoma cell apoptosis by regulating mitochondrial dynamics
Liyuan Li, Yan Meng, Xiaolin Wu, et al.
Cancer Science (2021) Vol. 112, Iss. 10, pp. 4013-4025
Open Access | Times Cited: 21

Showing 21 citing articles:

Delivery of short chain fatty acid butyrate to overcome Fusobacterium nucleatum-induced chemoresistance
Linfu Chen, Rui Zhao, Zheyu Kang, et al.
Journal of Controlled Release (2023) Vol. 363, pp. 43-56
Closed Access | Times Cited: 23
mTOR inhibition overcomes RSK3-mediated resistance to BET inhibitors in small cell lung cancer
Anju Kumari, Lisa Gesumaria, Yan-Jin Liu, et al.
JCI Insight (2023) Vol. 8, Iss. 5
Open Access | Times Cited: 16
Targeting mitochondria in dermatological therapy: beyond oxidative damage and skin aging
Tongyu C. Wikramanayake, Jérémy Chéret, Alec Sevilla, et al.
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 3, pp. 233-259
Open Access | Times Cited: 17
BETi enhance ATGL expression and its lipase activity to exert their antitumoral effects in triple-negative breast cancer (TNBC) cells
Teresa Rossi, Raffaella Zamponi, Mattea Chirico, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 10
Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints
Alexa C. Cannon, Konstantin Budagyan, Cristina Uribe‐Alvarez, et al.
Oncogene (2024) Vol. 43, Iss. 10, pp. 729-743
Open Access | Times Cited: 3
Unlocking the secrets of aging: Epigenetic reader BRD4 as the target to combatting aging-related diseases
Jiaxing Sun, Yu Gui, Shenghua Zhou, et al.
Journal of Advanced Research (2023) Vol. 63, pp. 207-218
Open Access | Times Cited: 8
Quercetin alleviates the toxicity of difenoconazole to the respiratory system of carp by reducing ROS accumulation and maintaining mitochondrial dynamic balance
Xiaomeng Ji, Jiajia Guo, Yeyun Ma, et al.
Toxicology and Applied Pharmacology (2024) Vol. 484, pp. 116860-116860
Closed Access | Times Cited: 2
Mitochondrial bioenergetics of breast cancer
Tashvinder Singh, Kangan Sharma, Laxmipriya Jena, et al.
Mitochondrion (2024) Vol. 79, pp. 101951-101951
Closed Access | Times Cited: 2
BET inhibitors (BETi) influence oxidative phosphorylation metabolism by affecting mitochondrial dynamics leading to alterations in apoptotic pathways in triple‐negative breast cancer (TNBC) cells
Teresa Rossi, Egidio Iorio, Mattea Chirico, et al.
Cell Proliferation (2024) Vol. 57, Iss. 12
Open Access | Times Cited: 2
Synthesis, crystal structure, computational investigation, molecular docking analysis and anti-lung cancer activity of novel (Z)-3-amino-2-(cyclohexylidenehydrazono)thiazolidin-4-one
Faraz Ghous, Soni Shukla, Ramesh Singh, et al.
Journal of Molecular Structure (2023) Vol. 1285, pp. 135462-135462
Closed Access | Times Cited: 6
Identification of exosomal miR-484 role in reprogramming mitochondrial metabolism in pancreatic cancer through Wnt/MAPK axis control
Tianyu Lin, Xiaofan Pu, Senhao Zhou, et al.
Pharmacological Research (2023) Vol. 197, pp. 106980-106980
Open Access | Times Cited: 6
Novel BRD4-p53 Inhibitor SDU-071 Suppresses Proliferation and Migration of MDA-MB-231 Triple-Negative Breast Cancer Cells
Shumei Wang, Kang Lei, Hsien‐Tsung Lai, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 4, pp. 1178-1190
Closed Access | Times Cited: 1
A novel 7-phenoxy-benzimidazole derivative as a potent and orally available BRD4 inhibitor for the treatment of melanoma
Yuhei Horai, N. Suda, Shinsuke Uchihashi, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117882-117882
Open Access | Times Cited: 1
Pueraria protein extract inhibits melanogenesis and promotes melanoma cell apoptosis through the regulation of MITF and mitochondrial‑related pathways
Yuchu Zhao, Shiting Yu, Yue Wang, et al.
Molecular Medicine Reports (2023) Vol. 27, Iss. 3
Open Access | Times Cited: 3
Review on: BRD4 inhibitors for anticancer research
Vindhya Vikram Singh, Shafqat Alauddin
Human Gene (2023) Vol. 37, pp. 201196-201196
Closed Access | Times Cited: 3
BET Protein Inhibitor JQ1 Ameliorates Experimental Peritoneal Damage by Inhibition of Inflammation and Oxidative Stress
Vanessa Marchant, Flavia Trionfetti, Lucía Tejedor-Santamaria, et al.
Antioxidants (2023) Vol. 12, Iss. 12, pp. 2055-2055
Open Access | Times Cited: 3
Bromo- and Extra-Terminal Domain Inhibitors Induce Mitochondrial Stress in Pancreatic Ductal Adenocarcinoma
Manjul Rana, Rita G. Kansal, Bijay Bisunke, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 8, pp. 936-946
Open Access | Times Cited: 2
BET Protein Inhibitor JQ1 Modulates Mitochondrial Dysfunction and Oxidative Stress Induced by Chronic Kidney Disease
Sandra Rayego‐Mateos, Pamela Estefanía Basantes, José Luis Morgado‐Pascual, et al.
Antioxidants (2023) Vol. 12, Iss. 5, pp. 1130-1130
Open Access | Times Cited: 1
Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints
Jonathan Chernoff, Alexa C. Cannon, Konstantin Budagyan, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Unique vulnerability ofRAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints
Alexa C. Cannon, Konstantin Budagyan, Cristina Uribe‐Alvarez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
BETi enhance ATGL expression and its lipase activity to exert their antitumoral effects in triple-negative breast cancer (TNBC).
Teresa Rossi, Raffaella Zamponi, Mattea Chirico, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top